PERIMENOPAUSE. MENOPAUSE. A LITTLE SPACE FOR YOU.

Comparisons 3 MIN READ

Stella vs Midi HRT: compare the appointments and the support around them

Two visit-led menopause services, with different self-pay fees and support features.

Stella and Midi both offer online menopause care built around clinical appointments. The decision is less about choosing a particular box of medicine and more about choosing a clinical relationship that fits your schedule, insurance and follow-up needs.

Their public self-pay visit prices differ, but that alone does not establish which will cost you less overall. This comparison uses their current service pages and keeps care fees, pharmacy costs and included support separate.

Compare one visit with one visit

Stella lists a $200 initial self-pay visit and $90 follow-ups. Midi lists $250 initially and $150 for continued-care visits. Using those published figures, an initial visit plus one follow-up would be $290 at Stella and $400 at Midi, before medicines, testing or other charges.

That is an arithmetic example, not a predicted treatment schedule or a complete quote. Different clinical needs can produce different visit patterns. The individual Stella review and Midi review explain the scope behind the numbers.

Let your actual insurance plan change the comparison

Both services discuss insurance participation. Ask each to check your specific plan, clinician and visit. Your deductible and coinsurance may matter more than the difference in advertised self-pay fees. A national insurer name does not tell you whether your exact plan participates.

Midi’s public page also has restrictions concerning Medicaid and Medi-Cal, including self-pay access for those beneficiaries. State that coverage accurately when asking about eligibility. Do not assume a service can accept you simply because you are willing to pay privately.

Decide what you want between clinical visits

Stella describes app-based coaching and lifestyle support alongside its appointments. That may be useful if you want help building routines or understanding educational material. Ask what contact is included and which issues are redirected to a prescriber.

With either service, request a clear route for medication questions and an explanation of when another paid appointment is needed. A message saying a refill request was received is different from a clinician reviewing new symptoms. The follow-up guide can help you plan those conversations.

Compare the proposed prescription separately

Both companies describe menopause prescribing, but neither a provider name nor a visit price tells you what your treatment should be. The route and formulation need to match an individual evaluation. One person may discuss a systemic medicine while another discusses local vaginal treatment or a nonhormonal option.

Ask where the prescription will be sent, what the pharmacy expects you to pay and whether alternatives are available if a product is out of stock. The local-pharmacy shortlist shows how that step affects the purchase.

Make the decision around a realistic week

Compare appointment availability when you can actually attend, whether the same clinician can see you again, and the plan for concerns that need an examination. Add insurance estimates and the proposed pharmacy cost to your notes. Those answers can outweigh a relatively small difference in one visit fee.

Stella may be especially worth investigating when coaching is high on your list. Midi may be worth investigating when its clinical access and plan participation fit your circumstances. Neither is a universal winner, and neither should be selected on the assumption that online care guarantees a prescription.

THE READING BEHIND THE ARTICLE

Sources & reading notes

Provider pages describe their own services and commercial terms. They are not independent evidence of better clinical results. Prices and access can change.

  1. Stella US: appointments, insurance and self-pay pricing
  2. Midi: HRT, insurance and visit pricing
  3. The Menopause Society: hormone therapy

Checked September 22, 2026. Our editorial process · Promotion disclosure. This article is educational and cannot determine which treatment is right for you.